News | May 15, 2024
Gujarat Themis Biosyn posts Q4 FY24 PAT at Rs. 15.88 Cr
The company has posted net profit of Rs. 59.16 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs. 59.16 crores for the Financial Year ended March 31, 2024
Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
Investing in Malaysia's largest clinic operator to expand the healthcare business
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
ORACEA is a trademark of Galderma Holdings, S.A.
New data for Tezspire and Breztri demonstrate AstraZeneca’s innovation and commitment to transform care in COPD
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes
Subscribe To Our Newsletter & Stay Updated
